{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=4+mL+Injection+of+Placebo&page=5", "query": { "intervention": "4 mL Injection of Placebo", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 332, "total_pages": 34, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=4+mL+Injection+of+Placebo&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=4+mL+Injection+of+Placebo&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T08:27:26.149Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04200092", "title": "Staccato® Granisetron Single Dose PK", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "0.5mg AZ-010; placebo", "type": "COMBINATION_PRODUCT" }, { "name": "1mg AZ-010", "type": "COMBINATION_PRODUCT" }, { "name": "3mg AZ-010", "type": "COMBINATION_PRODUCT" }, { "name": "AZ-010 1mg", "type": "COMBINATION_PRODUCT" }, { "name": "IV Granisetron 1mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG", "OTHER" ], "sponsor": "Nova Pneuma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 36, "start_date": "2019-11-04", "completion_date": "2020-01-31", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04200092" }, { "nct_id": "NCT02326298", "title": "An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis", "Plaque Psoriasis" ], "interventions": [ { "name": "Certolizumab Pegol", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB Biopharma S.P.R.L.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 234, "start_date": "2014-12-16", "completion_date": "2018-10-24", "has_results": true, "last_update_posted_date": "2019-11-07", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 8, "location_summary": "San Diego, California • West Des Moines, Iowa • Baton Rouge, Louisiana + 5 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "West Des Moines", "state": "Iowa" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02326298" }, { "nct_id": "NCT02317900", "title": "Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dengue" ], "interventions": [ { "name": "TV005", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "rDEN2∆30-7169", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 48, "start_date": "2014-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-02-01", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Burlington, Vermont", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT02317900" }, { "nct_id": "NCT04636229", "title": "Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Amniotic Suspension Allograft", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Organogenesis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 516, "start_date": "2020-12-14", "completion_date": "2025-08-19", "has_results": false, "last_update_posted_date": "2025-10-16", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 38, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Glendale, Arizona + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04636229" }, { "nct_id": "NCT05526716", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia, Pneumococcal" ], "interventions": [ { "name": "V116", "type": "BIOLOGICAL" }, { "name": "QIV", "type": "BIOLOGICAL" }, { "name": "Matching Placebo for V116", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 1080, "start_date": "2022-09-23", "completion_date": "2023-06-21", "has_results": true, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 56, "location_summary": "Phoenix, Arizona • Canoga Park, California • La Mesa, California + 46 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05526716" }, { "nct_id": "NCT01753401", "title": "Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Systemic Lupus Erythematosus (SLE)" ], "interventions": [ { "name": "Acthar", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Steroid Drug", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2013-01", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2020-02-27", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 22, "location_summary": "Jonesboro, Arkansas • La Jolla, California • La Palma, California + 17 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01753401" }, { "nct_id": "NCT07205926", "title": "First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Shigella", "Diarrhea" ], "interventions": [ { "name": "IVT Shigella-04", "type": "BIOLOGICAL" }, { "name": "Placebo (0.9% saline)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Inventprise Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 60, "start_date": "2025-10-09", "completion_date": "2026-08-21", "has_results": false, "last_update_posted_date": "2025-11-19", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07205926" }, { "nct_id": "NCT03110770", "title": "VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Zika Virus", "Zika Virus Infection", "Virus Diseases", "Flavivirus Infections", "Flaviviral Diseases", "Flaviviridae Infections", "RNA Virus Infections" ], "interventions": [ { "name": "VRC-ZKADNA090-00-VP", "type": "BIOLOGICAL" }, { "name": "VRC-PBSPLA043-00-VP", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "15 Years to 35 Years" }, "enrollment_count": 2428, "start_date": "2017-03-29", "completion_date": "2019-10-04", "has_results": true, "last_update_posted_date": "2024-01-31", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 3, "location_summary": "Miami, Florida • Edinburg, Texas • Houston, Texas", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Edinburg", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03110770" }, { "nct_id": "NCT02935686", "title": "A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ad26.Mos4.HIV", "type": "BIOLOGICAL" }, { "name": "Clade C gp140 plus adjuvant", "type": "BIOLOGICAL" }, { "name": "Clade C gp140/Mosaic gp140 plus adjuvant", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "gp140 HIV Bivalent Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Janssen Vaccines & Prevention B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2017-03-31", "completion_date": "2023-11-22", "has_results": true, "last_update_posted_date": "2025-05-25", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 11, "location_summary": "Birmingham, Alabama • San Francisco, California • Decatur, Georgia + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02935686" }, { "nct_id": "NCT05655221", "title": "A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nonalcoholic Steatohepatitis" ], "interventions": [ { "name": "B1344", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Tasly Biopharmaceuticals Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 56, "start_date": "2022-08-30", "completion_date": "2024-01-30", "has_results": false, "last_update_posted_date": "2022-12-19", "last_synced_at": "2026-10-17T08:27:26.149Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05655221" } ] }